• A man aged 50 or older?

• A man was older than 40 years with a family history of prostate cancer?

• Having a prostate-specific antigen (PSA) level between 2 and 10 ng/mL?

• Speaking with your doctor or concerned about an initial or repeat prostate biopsy?

If yes, The AcornUPro-SEEK Test may be right for you.

The AcornUPro-SEEK is a simple, non-DRE, and innovative urine test to detect PCa. It exhibits high sensitivity, facilitating accurate diagnosis of PCa , effectively for clinically significant prostate cancer. Additionally, high specificity can rule out PCa and avoid unnecessary biopsies. Especially with a negative predictive value (NPV) of 92%, if the test identifies a very low risk, the physician can be confident that there is a 92% likelihood that the patient does not have GS≥7 PCa and can therefore avoid a biopsy.

AcornUPro-SEEK enables you and your urologist to better understand your individual risk of prostate cancer and determine whether a prostate biopsy is necessary or can be avoided.

It is non-invasive, and easy-to-use. You do not need to visit the hospital. You only need to collect a urine sample at home and deliver it to us.

AcornUPro-SEEK provides a personalized risk score for you.

Results are usually written as "positive" or "negative".

• A positive result indicates a high risk of prostate cancer. It is recommended to follow your doctor's advice, consider results of other tests for a comprehensive evaluation, and schedule associated examinations if necessary.
• A negative result indicates a low risk of prostate cancer. It is advisable to consult with a clinical physician, maintain healthy lifestyle habits, and undergo regular physical examinations.